Brainsway Deep TMS Therapy - for Brain Disorder Treatment

Active Clinical Trials

Following is a list of active clinical trials involving Brainsway Deep TMS (Transcranial Magnetic Stimulation).

  • New Hope for Your PTSD

    Take Part in an FDA Approved Study for PTSD with the latest Deep TMS Technology

    About Brainsway Deep TMS

    Brainsway* Deep TMS is an innovative, revolutionary technology for the treatment of brain disorders such as PTSD. Deep TMS non-invasively stimulates the brain regions responsible for PTSD using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems. The device has been cleared by the FDA for treating depression, and has been studied in over 60 clinical trials around the world. 

    The treatment does not entail systemic side effects, which are effects deriving from medication entering the bloodstream and circulating throughout the body.

    Read More
  • Need help with your smoking addiction?

    Take Part in an FDA Approved Study for Smoking Cessation with the latest Deep TMS Technology

    About Brainsway Deep TMS

    Brainsway* Deep TMS is an innovative, revolutionary technology for the treatment of different brain disorders. Deep TMS non-invasively stimulates the brain regions responsible for the smoking addiction using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems. The device has been cleared by the FDA for treating depression, and has been studied in over 60 clinical trials around the world. 

    The treatment does not entail systemic side effects, which are effects deriving from medication entering the bloodstream and circulating throughout the body.

    Read More
  • New Hope for Bipolar Patients

    Take Part in an FDA Approved Study for Bipolar Depression with the latest Deep TMS Technology

    About Brainsway Deep TMS

    Brainsway* Deep TMS is an innovative, revolutionary technology for the treatment of brain disorders such as Bipolar Disorder. Deep TMS non-invasively stimulates the brain regions responsible for Bipolar Disorder using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems. The device has been cleared by the FDA for treating depression, and has been studied in over 60 clinical trials around the world. 

    The treatment does not entail systemic side effects, which are effects deriving from medication entering the bloodstream and circulating throughout the body.

    Read More
  • Evaluation of Deep TMS as an Aid to Smoking Cessation

    View study info

    Read More
  • Stroke Rehabilitation - Double-Blind Placebo Control Safety and Feasibility Study

    Hadassah Medical Organization, Jerusalem, Israel

    1 March, 2009

    A clinical trial using Brainsway®'s Deep TMS device for the rehabilitation of stroke patients has begun.

    The trial is designed determine the safety and efficacy of deep transcranial magnetic stimulation (TMS) in treating acute ischemic stroke (stroke resulting from a blood clot in the brain).

    Read More
  • A Randomized Sham-Controlled Study of H-Coil Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Late-Life Depression

    University of Toronto, Faculty of Medicine, Centre for Addiction & Mental Health, Canada

    20 March 2013

    Read More
  • Controlled trial of 1 Hz Deep transcranial magnetic stimulation for treatment of temporal lobe epilepsy.

    Children’s Hospital Boston (Harvard Medical School), USA

    15 November 2012

    Read More
  • Alzheimer's Disease - Double-Blind Placebo Control Safety and Feasibility Study

    Ichilov Medical Center, Tel-Aviv, Israel

    25 May, 2009

    The Purpose of the clinical trial is To evaluate the efficacy of Brainsway® Deep Transcranial Magnetic Stimulation (Deep TMS) with an improved H-coil, which targets deep brain structures, in the treatment of Alzheimer's patients concomitantly treated with drugs to which they previously failed to respond, or responded only partially.

    Read More
  • A Pilot Study to Determine the Safety and Efficacy of H-Coil Deep Transcranial magnetic Stimulation in treatment resistant Anorexia Nervosa

    1 March 2014

    University of Toronto, Faculty of Medicine, Centre for Addiction & Mental Health, Canada

    Read More

© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use